title: Crigler-Najjar syndrome type I in Tunisia may be associated with a founder effect related to the Q357R mutation within the UGT1 gene.
authors.forename: Jeanne
authors.initials: J
authors.lastname: Francoual
authors.forename: Armelle
authors.initials: A
authors.lastname: Rivierre
authors.forename: Chahnez
authors.initials: C
authors.lastname: Mokrani
authors.forename: Naïma
authors.initials: N
authors.lastname: Khrouf
authors.forename: Frédéric
authors.initials: F
authors.lastname: Gottrand
authors.forename: Anne
authors.initials: A
authors.lastname: Myara
authors.forename: Béatrice
authors.initials: B
authors.lastname: Le Bihan
authors.forename: Liliane
authors.initials: L
authors.lastname: Capel
authors.forename: Albert
authors.initials: A
authors.lastname: Lindenbaum
authors.forename: Philippe
authors.initials: P
authors.lastname: Labrune
mesh_terms: D019943:Amino Acid Substitution / Q000235:genetics*; D001120:Arginine / Q000235:genetics*; D003414:Crigler-Najjar Syndrome / Q000453:epidemiology / Q000235:genetics*; D018703:Founder Effect; D005973:Glutamine / Q000235:genetics*; D006801:Humans; D009004:Monosaccharide Transport Proteins / Q000172:deficiency / Q000235:genetics*; D009154:Mutation / Q000235:genetics*; D014416:Tunisia / Q000453:epidemiology; D000099237:UDP-Galactose Translocators
chemical_list: D001120:Arginine; D005973:Glutamine; D009004:Monosaccharide Transport Proteins; D000099237:UDP-Galactose Translocators